Vladimer Darsalia Selected Research

Vladimer Darsalia Research Topics

Disease

27	Stroke (Strokes) 02/2022 - 06/2003
18	Type 2 Diabetes Mellitus (MODY) 02/2022 - 05/2012
4	Atrophy 02/2022 - 01/2019
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 06/2003
3	Insulin Resistance 02/2022 - 10/2021
3	Neuroinflammatory Diseases 12/2021 - 01/2014
3	Hyperglycemia 11/2020 - 01/2018
3	Cognitive Dysfunction 11/2020 - 12/2016
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2010
2	Brain Injuries (Brain Injury) 01/2021 - 01/2014
2	Obesity 01/2019 - 04/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2006
2	Ischemic Stroke 01/2018 - 09/2011
1	Cicatrix (Scar) 02/2022
1	Weight Loss (Weight Reduction) 12/2021
1	Ischemia 01/2021
1	Weight Gain 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Nervous System Diseases (Neurological Disorders) 09/2014
1	Body Weight (Weight, Body) 04/2013
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2013
1	Chorea (Rheumatic Chorea) 06/2003

Drug/Important Bio-Agent (IBA)

8	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 04/2013
6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 04/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2022 - 04/2013
5	Glucagon-Like Peptide-1 ReceptorIBA 02/2022 - 05/2012
5	LinagliptinIBA 01/2019 - 04/2013
5	Neuroprotective AgentsIBA 05/2015 - 05/2012
4	ParvalbuminsIBA 12/2021 - 06/2003
3	Exenatide (Byetta)FDA Link 02/2022 - 01/2014
3	Glucagon-Like Peptide ReceptorsIBA 01/2018 - 01/2014
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2014 - 05/2014
2	Pharmaceutical PreparationsIBA 05/2012 - 12/2010
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2021
1	AR-R 17779IBA 01/2021
1	SugarsIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	Myelin Basic ProteinIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	NeurograninIBA 01/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 09/2014
1	CytokinesIBA 01/2014
1	GalaninIBA 10/2013
1	Lys(15)-Arg(16)-Leu(27)- vasoactive intestinal peptide (1-7)-GRF (8-27)IBA 04/2013
1	glimepiride (Amarel)FDA LinkGeneric 04/2013
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 04/2013
1	Insulin-Like PeptidesIBA 04/2012
1	PlasticsIBA 04/2012
1	Transcription Factors (Transcription Factor)IBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 04/2012
1	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 04/2012
1	Dopamine (Intropin)FDA LinkGeneric 12/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2008
1	CaspasesIBA 03/2006
1	gamma-Aminobutyric Acid (GABA)IBA 06/2003
1	Green Fluorescent ProteinsIBA 06/2003
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2003
1	Cholinergic Agents (Cholinergics)IBA 06/2003
1	Neuropeptide YIBA 06/2003

Therapy/Procedure

7	Therapeutics 01/2019 - 12/2006
4	Transplantation 01/2018 - 08/2007
2	Stem Cell Transplantation 01/2018 - 09/2011
1	Activities of Daily Living (ADL) 01/2019
1	Thrombectomy 01/2018